Five Prime Therapeutics Obtains $10,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=867b7650-9443-4850-a7a1-dafe58f94013&Preview=1
Date
4/20/2012
Company Name
Five Prime Therapeutics
Mailing Address
Two Corporate Dr South San Francisco, CA 94080
Company Description
FivePrime is a drug discovery and development company primarily focused on therapeutic proteins. The Company is creating a new paradigm in drug discovery by leveraging the Pharmanome(TM) – the entire set of pharmaceutically relevant genes and proteins.
Website
http://www.fiveprime.com
Transaction Type
Venture Equity
Transaction Amount
$10,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed